G M McKenzie, R J Gordon, K Viik. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Amphetamine/therapeutic useAnimalsAtropine/therapeutic useBehavior, Animal/drug effectsCatecholamines/metabolismCatsCaudate Nucleus/drug effectsCaudate Nucleus/metabolismChlorpromazine/therapeutic useCholinesterase Inhibitors/therapeutic useChromatography, Thin LayerDihydroxyphenylalanine/metabolismDisease Models, AnimalDopamine/metabolismElectric StimulationGanglionic Blockers/therapeutic useMovement Disorders/chemically inducedMovement Disorders/drug therapyMovement Disorders/metabolismPhenylacetates/metabolismPicrotoxin/therapeutic useRatsTranquilizing Agents/therapeutic useTritiumTubocurarineTyrosine/metabolism
Substances： See more » CatecholaminesCholinesterase InhibitorsGanglionic BlockersPhenylacetatesTranquilizing AgentsTritiumPicrotoxinTyrosineDihydroxyphenylalanineAtropineAmphetamineChlorpromazineDopamineTubocurarine
Year: 1972 PMID： 4404908 DOI： 10.1016/0006-8993(72)90651-8
Source DB: PubMed Journal: Brain Res ISSN： 0006-8993 Impact factor: 3.252